Is Creatine Monohydrate Safe with Tirzepatide (Mounjaro)?
Free · No account · based on published sources including NIH ODS, FDA drug labels, and peer-reviewed literature
Creatine (3–5g/day) is considered safe alongside tirzepatide and is a reasonable strategy to preserve lean muscle mass during significant weight loss. Ensure adequate hydration as both GLP-1 therapy and creatine loading increase fluid demands.
Why this interaction occurs
Significant caloric restriction during tirzepatide therapy carries risk of lean muscle mass loss. Creatine supports phosphocreatine replenishment in muscle, improving exercise capacity and attenuating muscle catabolism. No pharmacokinetic interaction with tirzepatide is known. The primary concern is hydration status, as creatine draws intracellular water and GLP-1 induced nausea/vomiting may compromise fluid intake.
Evidence
Evidence level: limited.
Reported safety data
The FDA’s adverse event reporting system (FAERS) has received 94,106 reports mentioning Tirzepatide (Mounjaro). This reflects reported cases involving the medication in general — not confirmed causation, and not specific to the Tirzepatide (Mounjaro) + supplement combination on this page.
FAERS reports are voluntary and cannot prove that a drug caused an event. Do not use report counts to assess the safety of this specific drug-supplement pair.
Frequently asked questions
Related interactions
All Creatine Monohydrate interactions → · All Tirzepatide (Mounjaro) interactions →
Already checked this one — check your whole list
Educational only — not medical advice.
Always confirm with your doctor or pharmacist.